Biglari Holdings Inc. News Release

Biglari Holdings Inc. (NYSE: BH.A; BH) announces its results for the third quarter and first nine months of 2025. Biglari Holdings Inc.'s earnings for the third quarter and first nine months of 2025 and 2024 are summarized below. To become fully apprised of our results, shareholders should carefully study our 10-Q, which has been posted […]

InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria

(NASDAQ:IFRX), Company expects to host a webcast to discuss the topline data on Monday, November 10 at 8:00 AM EST / 2:00 PM CET Company also expects to publish third quarter 2025 financial results on the same day pre-market JENA, Germany, Nov. 07, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering

Real-World Evidence Studies of XPHOZAH(R) (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

(NasdaqGM:ARDX), WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study of XPHOZAH, at American Society of Nephrology's

Arhaus Opens Its First Montana Showroom in Bozeman

(NASDAQ:ARHS), BOSTON HEIGHTS, Ohio, Nov. 07, 2025 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, today announced the opening of its new 12,006-square-foot showroom in Bozeman, Montana. Located in Gallatin Crossing–Bozeman's premier shopping and lifestyle destination surrounded by sweeping mountain views–the new showroom marks Arhaus'

BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

(NasdaqGM:BLLN), MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering of 5,233,765 shares of its Class A common stock, which includes the exercise in full

Viasat Releases Second Quarter Fiscal Year 2026 Financial Results

(NASDAQ:VSAT), CARLSBAD, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its second quarter fiscal year 2026 financial results in a letter to shareholders, which, along with webcast slides, is now posted to the Investor Relations section of Viasat's website. As previously announced, Viasat will

Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights

(NASDAQ:RKDA), — Zola(R) year-to-date revenues increase 26% year over year —— Arcadia gross profit margins exceed 30% for 11th straight quarter —— Arcadia cash balance declines by only $257K to $1.1M — DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) — Arcadia Biosciences, Inc.(R) (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its

Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025

(NasdaqGM:NNOX), PETACH TIKVA, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2025, before market open on Thursday, November 20, 2025. Erez Meltzer, Chief Executive Officer and

Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update

(NASDAQ:SRZN), SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the third quarter ended September 30, 2025,

Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings

(TSX:LAR),(NYSE:LAR), ZUG, Switzerland, Nov. 07, 2025 (GLOBE NEWSWIRE) — Lithium Argentina AG (“Lithium Argentina” or the “Company“) (TSX: LAR) (NYSE: LAR) will release its third quarter 2025 earnings results before market open on Monday, November 10, 2025. In conjunction, the Company will also release the results of the Scoping Study (“Scoping Study“) for the Pozuelos-Pastos

Scroll to Top